biotech
Microbia Collaborates with A*Star
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on July 26, 2005
BlogPicture

Image: Precision Engineering
by Microbia

Secondary metabolites produced from fermentation of actinomycetes are one of the most important sources of pharmaceuticals. Microbia, Inc. announced yesterday that its Precision Engineering business unit has entered into a research collaboration with A*STAR's Bioprocessing Technology Institute (BTI) in Singapore to improve the efficiency of secondary metabolite production from actinomycete bacteria. This will allow BTI scientists to use Microbia's profiling and informatic methods to speed up production of actinomycete metabolites for use in cancer therapeutics.
"By combining Microbia's powerful platform for engineering industrial microbes with our strong technology base in, and deep knowledge of, genomics and process development, we aim to create a new paradigm for more efficient and cost-effective production of pharmaceutical compounds from actinomycetes," said Miranda Yap, Executive Director of BTI.


Download the press release here.



Permalink: Microbia Collaborates with A*Star
Tags: microbial  antibiotics  biotech  microbia  a*star  microbia+collaborates  proteomics+bioinformatics  corpor 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/7961
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Microbia Collaborates with A*Star:

  • Currently 6.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.50 out of 4 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!